These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34544342)

  • 1. Recent Studies on Neglected Drug Design.
    de Sousa NF; Scotti L; Rodrigues GCS; de Moura ÉP; Costa Barros RPB; Sessions ZL; Muratov EN; Scotti MT
    Curr Top Med Chem; 2021; 21(21):1943-1974. PubMed ID: 34544342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases.
    Herrera Acevedo C; Scotti L; Feitosa Alves M; Formiga Melo Diniz MF; Scotti MT
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28054952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to advance drug discovery for neglected tropical diseases.
    Ferreira LLG; de Moraes J; Andricopulo AD
    Drug Discov Today; 2022 Aug; 27(8):2278-2287. PubMed ID: 35398562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug design for neglected disease in Brazil.
    Giarolla J; Ferreira EI
    Mini Rev Med Chem; 2015; 15(3):220-42. PubMed ID: 25769971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.
    Santos SS; de Araújo RV; Giarolla J; Seoud OE; Ferreira EI
    Int J Antimicrob Agents; 2020 Apr; 55(4):105906. PubMed ID: 31987883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Medicinal Chemistry to Human Health: Current Approaches to Drug Discovery for Cancer and Neglected Tropical Diseases.
    Ferreira LG; Oliva G; Andricopulo AD
    An Acad Bras Cienc; 2018; 90(1 Suppl 1):645-661. PubMed ID: 29451603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue.
    Boniface PK; Ferreira EI
    Phytother Res; 2019 Oct; 33(10):2473-2517. PubMed ID: 31441148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmaniasis and Chagas disease: Is there hope in nanotechnology to fight neglected tropical diseases?
    Scariot DB; Staneviciute A; Zhu J; Li X; Scott EA; Engman DM
    Front Cell Infect Microbiol; 2022; 12():1000972. PubMed ID: 36189341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases.
    Nascimento IJDS; Cavalcanti MAT; de Moura RO
    Eur J Med Chem; 2023 Oct; 258():115550. PubMed ID: 37336067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discovery and development for neglected diseases: the DNDi model.
    Chatelain E; Ioset JR
    Drug Des Devel Ther; 2011 Mar; 5():175-81. PubMed ID: 21552487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
    Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
    Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
    Bilbe G
    Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases.
    Dos Santos Fernandes GF; Pavan AR; Dos Santos JL
    Curr Pharm Des; 2018; 24(12):1325-1340. PubMed ID: 29663875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empowering neglected tropical disease drug discovery with translational medicinal chemistry.
    Ferreira LL; Andricopulo AD
    Future Med Chem; 2023 Jun; 15(12):1015-1017. PubMed ID: 37435677
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential Triazole-based Molecules for the Treatment of Neglected Diseases.
    Mantoani SP; de Andrade P; Chierrito TPC; Figueredo AS; Carvalho I
    Curr Med Chem; 2019; 26(23):4403-4434. PubMed ID: 28748757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of quinones with highlighted biological applications: A critical update on the strategies towards bioactive compounds with emphasis on lapachones.
    da Silva Júnior EN; Jardim GAM; Jacob C; Dhawa U; Ackermann L; de Castro SL
    Eur J Med Chem; 2019 Oct; 179():863-915. PubMed ID: 31306817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Privileged Structures in the Design of Potential Drug Candidates for Neglected Diseases.
    Leite ACL; Espíndola JWP; de Oliveira Cardoso MV; de Oliveira Filho GB
    Curr Med Chem; 2019; 26(23):4323-4354. PubMed ID: 29065822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial (Thematic Issue: Medicinal Chemistry Applied to Natural Products in Neglected Drug Discovery).
    Scotti L; Scotti MT; Mendonça FJ
    Comb Chem High Throughput Screen; 2016; 19(7):514-5. PubMed ID: 27682866
    [No Abstract]   [Full Text] [Related]  

  • 20. Fragment-based drug discovery as alternative strategy to the drug development for neglected diseases.
    Mello JDFRE; Gomes RA; Vital-Fujii DG; Ferreira GM; Trossini GHG
    Chem Biol Drug Des; 2017 Dec; 90(6):1067-1078. PubMed ID: 28547936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.